Ambroxol pastillas para que sirve
There have been reports of serious skin reactions associated with the administration of ambroxol. If you develop a skin rash (including mucosal lesions of, for example, the mouth, throat, nose, eyes and genitals), stop using Ambroxol cinfa and consult your doctor immediately.
If you are pregnant or breast-feeding, think you may be pregnant or intend to become pregnant, consult your pharmacist before using this medicine. Treatment with ambroxol has not been shown to be harmful during pregnancy. However, your pharmacist will assess the benefit/risk of its administration.
If you have taken too much Ambroxol cinfa, consult your pharmacist immediately. Take this leaflet with you. No symptoms of overdosage have been reported to date. Treatment in this case will be symptomatic.
Ambroxol cinfa 15 mg/5 ml is supplied in topaz-coloured glass bottles fitted with a white aluminium cap or cylindrical capsule varnished on the inside with a low-density polyethylene foam closure or in topaz PET bottles fitted with a polypropylene cap.
Oral route:Intravenous route:Other guideline:1.25-1.6 mg/kg/day orally, intravenously, intramuscularly or subcutaneously, divided into 2-3 doses. Intramuscular and subcutaneous administration is outside the specifications of the data sheet (E: off-label).Patients with renal and hepatic insufficiency:In patients with impaired renal function or severe liver disease, the drug should be administered only under medical supervision and the dose may be reduced or the administration intervals may be increased. Because the drug is metabolized in the liver and eliminated by the kidneys, accumulation of hepatic metabolites of ambroxol is to be expected in case of severe renal insufficiency.Administration:
Ambroxol mucotoxol what it is used for
This drug is used for the secretolytic treatment of productive cough in acute or chronic bronchopulmonary conditions associated with excessive mucus secretion and difficulty in mucus transport.
Serious skin reactions associated with the administration of ambroxol hydrochloride have been described. If you experience skin lesions on mucous membranes such as the mouth, throat, nose, eyes and genitals, discontinue use of Ambroxol Unither Pharmaceuticals and consult your physician immediately.
Because of the possibility of accumulation of secretions, ambroxol hydrochloride should be used with caution in case of impaired bronchomotor function and large amounts of secretion (e.g., in rare ciliary dyskinesia syndrome).
Follow exactly the instructions for administration contained in this package leaflet or as directed by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, telephone 91 562 04 20, indicating the medicine and the quantity ingested.
Ambroxol for covid
There have been reports of serious skin reactions associated with administration of ambroxol hydrochloride. If you develop a skin rash (including mucosal lesions of, for example, the mouth, throat, nose, eyes and genitals), stop using Mucosan and consult your doctor immediately.
No harmful effects have been observed during pregnancy. However, the usual precautions regarding the use of medicines during pregnancy should be observed. The use of Mucosan is not recommended especially in the first trimester of pregnancy.
If you have taken more Mucosan than you should, you may experience nausea or any other side effect described in section 4 Possible side effects. In case of overdose or accidental ingestion, consult your doctor or pharmacist, or call the Toxicological Information Service, telephone 915 620 420, indicating the medicine and the amount ingested.